Medpage Today on MSN2d
Treatment of Oligometastatic EGFR-Mutant Lung Cancer
EGFR tyrosine kinase inhibitors (TKIs) are effective treatments for EGFR-mutant non-small cell lung cancer (NSCLC). However, ...
Nursing in Practice9d
Lung cancer – looking beyond smoke and mirrors
There are many sub-types of NSCLC, but the three main ones are adenocarcinoma, squamous cell carcinoma and large cell ...
Cure Today2d
Radiotherapy and EGFR-TKIs May Improve Treatment Outcomes in Lung Cancer
CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...
Lung cancer survivor grateful for advancements in treatment at April Sampson Cancer Center
At the April Sampson Cancer Center on Monday, Tom Uhlman shared his story as part of the Shine a Light on Lung Cancer ...
Terminal lung cancer patient shares five warning signs that can be overlooked 'for years'
A mother who was diagnosed with stage 4 lung cancer at just 34 years old has outlined five symptoms that she ignored and ...
Medscape8d
Two Lung Cancer Drugs Recommended by EMA
Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.
Cure Today2d
Magrolimab-Chemo Combo Improves Responses in Metastatic NSCLC
Patients with metastatic non-small cell lung cancer and high CD47 expression showed improved responses to treatment with magrolimab plus docetaxel. Improved outcomes were seen with magrolimab plus ...
Daily Journal2d
Hands-on training: Center Grove student helps IU lab with cancer research
Small cell lung cancer is a fast-growing type of lung cancer known for its metastatic spread and resistance to treatment.
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer
Calidi Biotherapeutics, Inc. recently disclosed information revealing the latest advancements in its targeted antitumor virotherapies. The company’s press release, titled “Calidi Biotherapeutics ...